Detalhe da pesquisa
1.
Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study.
Horm Metab Res
; 55(5): 323-332, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764327
2.
The Importance of DHEA-S Levels in Cushing's Syndrome; Is There a Cut-off Value in the Differential Diagnosis?
Horm Metab Res
; 54(4): 232-237, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413744
3.
Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study.
Endocr Pract
; 28(1): 30-35, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508902
4.
External Validation of the GREAT Score in Turkish Patients with Graves' Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study.
Horm Metab Res
; 51(10): 627-633, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499558
5.
Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
Endocr J
; 63(2): 111-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581584
6.
The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
Endocrine
; 83(3): 700-707, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736822
7.
Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study.
Endocrine
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570387
8.
The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves' hyperthyroidism: a multicentre study.
Endokrynol Pol
; 71(3): 207-212, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154572